I'm not new to the stock market but I have just started researching Recce. From what I can tell the upcoming human trial is very exciting for the company and shareholders but the news of this looks to have been well disseminated and in all likelihood well anticipated so the latest news may not trouble the current share price/market cap very much. Truly new news may be required for that to be the case going forward.
Also, it looks like the market is having another risk-off day today so that doesn't help but who knows what tomorrow or next week will bring.
The Doherty/CSIRO in-vitro/ex-vivo test results for COVID-19 shouldn't be too far away and may help the share price if they prove positive.
Reliable share price forecasting, particularly over longer-term horizons, in these hot/cold markets is a tough call so have a pinch of salt on hand regarding such speculations. I have no idea what the share price will be in a year or two under a planets-aligning type of scenario. Time will tell should that occur.
RCE Price at posting:
$1.61 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)